Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Public ClinicalTrials.gov record NCT00116649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label Safety and Pharmacokinetic Study of AldaraTM (Imiquimod) Cream, 5% for One, Two, or Three Treatment Cycles to Surface Areas Greater Than 25 cm2 With Actinic Keratosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Actinic keratosis (AK) is a skin condition that shows up on skin routinely exposed to the sun, such as the face, scalp, shoulders, chest, back, arms, and hands. The purpose of this study is to evaluate the safety of one, two, or three cycles of imiquimod for the treatment of AK. The AK lesions treated can be in adjacent and nonadjacent areas of the head, torso, and extremities. The total surface area for the AK lesions must be greater than 25 cm2. The secondary objective is to evaluate the effectiveness of treatment with imiquimod in people with large surface areas of AK.
Study identification
- NCT ID
- NCT00116649
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 551 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2005 (Type not available)
- Primary completion
- May 2007 (Actual)
- Completion
- May 2007 (Actual)
- Last update posted
- Jul 20, 2010
2005 – 2007
United States locations
- U.S. sites
- 32
- U.S. states
- 19
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85044 | — |
| Not listed | Encino | California | 91436 | — |
| Not listed | Los Angeles | California | 90045 | — |
| Not listed | Riverside | California | 92506 | — |
| Not listed | San Diego | California | 92117 | — |
| Not listed | Santa Monica | California | 90404 | — |
| Not listed | Denver | Colorado | 80210 | — |
| Not listed | New Britain | Connecticut | 06052 | — |
| Not listed | Coral Gables | Florida | 33134 | — |
| Not listed | Hollywood | Florida | 33021 | — |
| Not listed | Miami | Florida | 33175 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Arlington Heights | Illinois | 60005 | — |
| Not listed | Indianapolis | Indiana | 46256 | — |
| Not listed | Metairie | Louisiana | 70006 | — |
| Not listed | Boston | Massachusetts | 02118 | — |
| Not listed | Chaska | Minnesota | 55318 | — |
| Not listed | Henderson | Nevada | 89014 | — |
| Not listed | Henderson | Nevada | 89052 | — |
| Not listed | Reno | Nevada | 89509 | — |
| Not listed | Reno | Nevada | 89521 | — |
| Not listed | New York | New York | 10021 | — |
| Not listed | High Point | North Carolina | 27262 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Winston-Salem | North Carolina | 27106 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Flourtown | Pennsylvania | 19031 | — |
| Not listed | Arlington | Texas | 76011 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Woodbridge | Virginia | 22191 | — |
| Not listed | Spokane | Washington | 99204 | — |
| Not listed | Milwaukee | Wisconsin | 53207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00116649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 20, 2010 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00116649 live on ClinicalTrials.gov.